[
1. Greenberg MI, Waksman J, Curtis J. Silicosis: a review. Dis Mon 2007; 53 (8): 394-416.10.1016/j.disamonth.2007.09.02017976433
]Search in Google Scholar
[
2. Pollard KM. Silica, Silicosis, and Autoimmunity. Front Immunol 2016; 7: 97.10.3389/fimmu.2016.00097478655127014276
]Search in Google Scholar
[
3. Barnes H, Goh NSL, Leong TL, Hoy R. Silica associated lung disease: An old world exposure in modern industries. Respirology 2019; 24 (12): 1165-75.10.1111/resp.1369531517432
]Search in Google Scholar
[
4. Adamcakova J, Mokra D. New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis. Int J Mol Sci 2021; 22 (8): 4162.10.3390/ijms22084162807289633920534
]Search in Google Scholar
[
5. Schwalfenberg GK. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks). J Nutr Metab 2021; 2021: 9949453.10.1155/2021/9949453821152534221501
]Search in Google Scholar
[
6. Vallyathan V, Castranova V, Pack D, Leonard S, Shumaker J, Hubbs AF, Shoemaker DA, Ramsey DM, Pretty JR, McLaurin JL, et al. Freshly fractured quartz inhalation leads to enhanced lung injury and inflammation. Potential role of free radicals. Am J Respir Crit Care Med 1995; 152 (3): 1003-9.10.1164/ajrccm.152.3.76637757663775
]Search in Google Scholar
[
7. Hamilton RF Jr, Thakur SA, Holian A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med 2008; 44 (7): 1246-58.10.1016/j.freeradbiomed.2007.12.027268095518226603
]Search in Google Scholar
[
8. Porter DW, Ye J, Ma J, Barger M, Robinson VA, Ramsey D, McLaurin J, Khan A, Landsittel D, Teass A, Castranova V. Time course of pulmonary response of rats to inhalation of crystalline silica: NF-kappa B activation, inflammation, cytokine production, and damage. Inhal Toxicol 2002; 14 (4): 349-67.10.1080/0895837025287099812028809
]Search in Google Scholar
[
9. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF- B signaling. Cell Res 2011; 21 (1): 103-15.10.1038/cr.2010.178319340021187859
]Search in Google Scholar
[
10. Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 2014; 5: 352.10.3389/fphys.2014.00352417932325324778
]Search in Google Scholar
[
11. Seo MS, Kim JK, Lim Y, Kang SW, Cho YJ, Lee WK, Kim HJ, Cho KK, Lee KH, Rhee SG. Rapid degradation of PrxI and PrxII induced by silica in Rat2 cells. Biochem Biophys Res Commun 1999; 265 (2): 541-4.10.1006/bbrc.1999.170910558905
]Search in Google Scholar
[
12. Biswas R, Bunderson-Schelvan M, Holian A. Potential role of the inflammasome-derived inflamma tory cytokines in pulmonary fibrosis. Pulm Med 2011; 2011: 105707.10.1155/2011/105707310930921660282
]Search in Google Scholar
[
13. Hu S, Zhao H, Al-Humadi NH, Yin XJ, Ma JK. Silica-induced apoptosis in alveolar macrophages: evidence of in vivo thiol depletion and the activation of mitochondrial pathway. J Toxicol Environ Health A 2006; 69 (13): 1261-84.10.1080/1528739050036187516754540
]Search in Google Scholar
[
14. Kim KH, Lee MS. Autophagy--a key player in cellular and body metabolism. Nat Rev Endocrinol 2014; 10 (6): 322-37.10.1038/nrendo.2014.3524663220
]Search in Google Scholar
[
15. Zhao H, Wang Y, Qiu T, Liu W, Yao P. Autophagy, an important therapeutic target for pulmonary fibrosis diseases. Clin Chim Acta 2020; 502: 139-47.10.1016/j.cca.2019.12.01631877297
]Search in Google Scholar
[
16. Adamcakova J, Mokra D. Herbal compounds in the treatment of pulmonary silicosis. Physiol Res 2021; 70 (Suppl 1): xxx (accepted for publication).10.33549/10.33549/physiolres.934817
]Search in Google Scholar
[
17. Huang H, Chen M, Liu F, Wu H, Wang J, Chen J, Liu M, Li X. N-acetylcysteine therapeutically protects against pulmonary fibrosis in a mouse model of silicosis. Biosci Rep 2019; 39: BSR20190681.10.1042/BSR20190681663945831273057
]Search in Google Scholar
[
18. Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res 2018; 52 (7): 751-62.10.1080/10715762.2018.146856429742938
]Search in Google Scholar
[
19. Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants (Basel) 2021; 10 (6): 967.10.3390/antiox10060967823402734208683
]Search in Google Scholar
[
20. Calverley P, Rogliani P, Papi A. Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review. Drug Saf 2021; 44 (3): 273-90.10.1007/s40264-020-01026-y789273333326056
]Search in Google Scholar
[
21. Stey C, Steurer J, Bachmann S, Medici TC, Tramèr MR. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 2000; 16 (2): 253-62.10.1034/j.1399-3003.2000.16b12.x
]Search in Google Scholar
[
22. Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther 2000; 22 (2): 209-21.10.1016/S0149-2918(00)88479-9
]Search in Google Scholar
[
23. Hansen NC, Skriver A, Brorsen-Riis L, Balsløv S, Evald T, Maltbaek N, Gunnersen G, Garsdal P, Sander P, Pedersen JZ, et al. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. Respir Med 1994; 88 (7): 531-5.10.1016/S0954-6111(05)80337-3
]Search in Google Scholar
[
24. Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, Yao WZ, Ma LJ, Li X, Raiteri L, Sardina M, Gao Y, Wang BS, Zhong NS; PANTHEON study group. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomized, double-blind placebo-controlled trial. Lancet Respir Med 2014; 2 (3): 187-94.10.1016/S2213-2600(13)70286-8
]Search in Google Scholar
[
25. Tse HN, Raiteri L, Wong KY, Yee KS, Ng LY, Wai KY, Loo CK, Chan MH. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest 2013; 144 (1): 106-18.10.1378/chest.12-235723348146
]Search in Google Scholar
[
26. Johnson K, McEvoy CE, Naqvi S, Wendt C, Reilkoff RA, Kunisaki KM, Wetherbee EE, Nelson D, Tirouvanziam R, Niewoehner DE. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis 2016; 11: 799-807.10.2147/COPD.S102375
]Search in Google Scholar
[
27. Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G; Idiopathic Pulmonary Fibrosis Clinical Research Network. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370 (22): 2093-101.10.1056/NEJMoa1401739411666424836309
]Search in Google Scholar
[
28. Oldham JM, Ma SF, Martinez FJ, Anstrom KJ, Raghu G, Schwartz DA, Valenzi E, Witt L, Lee C, Vij R, Huang Y, Strek ME, Noth I; IPFnet Investigators. TOLLIP, MUC5B, and the Response to NAcetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2015; 192 (12): 1475-82.10.1164/rccm.201505-1010OC473172326331942
]Search in Google Scholar
[
29. Mokra D, Tonhajzerova I, Pistekova H, Visnovcova Z, Drgova A, Mokry J, Calkovska A. Car dio -vascular effects of N-acetylcysteine in meconium-induced acute lung injury. Adv Exp Med Biol 2015; 832: 35-43.10.1007/5584_2014_425300682
]Search in Google Scholar
[
30. Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995; 152 (3): 1055-60.10.1164/ajrccm.152.3.76637837663783
]Search in Google Scholar
[
31. Niemi TT, Munsterhjelm E, Pöyhiä R, Hynninen MS, Salmenperä MT. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 2006; 17 (1): 29-34.10.1097/01.mbc.0000195922.26950.8916607076
]Search in Google Scholar
[
32. Chiew AL, Gluud C, Brok J, Buckley NA. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2018; 2 (2): CD003328.10.1002/14651858.CD003328.pub3649130329473717
]Search in Google Scholar
[
33. Yeh IJ, Wang TY, Lin JC, Lin TJ, Chang JS, Yen MC, Liu YH, Wu PL, Chen FW, Shih YL, Peng CY. Optimal Regimen of N-Acetylcysteine on Chromium-Induced Renal Cell Damage. Metabolites 2019; 9 (9):172.10.3390/metabo9090172678039631466266
]Search in Google Scholar
[
34. Ooi SL, Green R, Pak SC. N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence. Biomed Res Int 2018; 2018: 2469486.10.1155/2018/2469486621790030426004
]Search in Google Scholar
[
35. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, Dugo L, Calabrò G, Cucinotta G, De Sarro A, Caputi AP. Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol 2000; 130 (6): 1219–26.10.1038/sj.bjp.0703421157218110903958
]Search in Google Scholar
[
36. Crupi R, Gugliandolo E, Siracusa R, Impellizzeri D, Cordaro M, Di Paola R, Britti D, Cuzzocrea S. N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice. BMC Vet Res 2020; 16 (1): 13.10.1186/s12917-020-2234-9695869431931804
]Search in Google Scholar
[
37. Poncin S, Colin IM, Decallonne B, Clinckspooor I, Many MC, Denef JF, Gérard AC. N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro. Am J Pathol 2010; 177 (1): 219-28.10.2353/ajpath.2010.091253289366520489149
]Search in Google Scholar
[
38. Jorge-Aarón RM, Rosa-Ester MP. N-acetylcysteine as a potential treatment for COVID-19. Future Microbiol 2020; 15: 959-62.10.2217/fmb-2020-0074735941832662664
]Search in Google Scholar
[
39. Poe FL, Corn J. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Med Hypotheses 2020; 143: 109862.10.1016/j.mehy.2020.109862726108532504923
]Search in Google Scholar
[
40. Mokra D, Drgova A, Mokry J, Antosova M, Durdik P, Calkovska A. N-acetylcysteine effectively diminished meconium-induced oxidative stress in adult rabbits. J Physiol Pharmacol 2015; 66 (1): 101-10.
]Search in Google Scholar
[
41. Mokra D, Drgova A, Petras M, Mokry J, Antosova M, Calkovska A. N-acetylcysteine alleviates the meconium-induced acute lung injury. Adv Exp Med Biol 2015; 832: 59-67.10.1007/5584_2014_725300685
]Search in Google Scholar
[
42. Kopincová J, Mokrá D, Mikolka P, Kolomazník M, Čalkovská A. N-acetylcysteine advancement of surfactant therapy in experimental meconium aspiration syndrome: possible mechanisms. Physiol Res 2014; 63 (Suppl 4): S629-42.10.33549/physiolres.93293825669694
]Search in Google Scholar
[
43. Mikolka P, Kopincova J, Mikusiakova LT, Kosutova P, Calkovska A, Mokra D. Antiinflammatory Effect of N-Acetylcysteine Combined with Exogenous Surfactant in Meconium-Induced Lung Injury. Adv Exp Med Biol 2016; 934: 63-75.10.1007/5584_2016_1527283193
]Search in Google Scholar
[
44. Barrett EG, Johnston C, Oberdörster G, Finkelstein JN. Antioxidant treatment attenuates cytokine and chemokine levels in murine macrophages following silica exposure. Toxicol Appl Pharmacol 1999; 158 (3): 211-20.10.1006/taap.1999.871610438654
]Search in Google Scholar
[
45. Kang JL, Go YH, Hur KC, Castranova V. Silica-induced nuclear factor-kappaB activation: involvement of reactive oxygen species and protein tyrosine kinase activation. J Toxicol Environ Health A 2000; 60 (1): 27-46.10.1080/00984100015657410832616
]Search in Google Scholar
[
46. Hu S, Zhao H, Yin XJ, Ma JK. Role of mitochondria in silica-induced apoptosis of alveolar macrophages: inhibition of apoptosis by rhodamine 6G and N-acetyl-L-cysteine. J Toxicol Environ Health A 2007; 70 (17): 1403-15.10.1080/1528739070125199017687726
]Search in Google Scholar
[
47. Li N, Shi F, Wang X, Yang P, Sun K, Zhang L, Hao X, Li X, Li J, Jin Y. Silica dust exposure induces pulmonary fibrosis through autophagy signaling. Environ Toxicol 2021; 36 (7): 1269-77.10.1002/tox.2312433720480
]Search in Google Scholar
[
48. Zhang H, Yin G, Jiang H, Zhang C. High-dose N-acetylcysteine decreases silica-induced lung fibrosis in the rat. J Int Med Res 2013; 41 (4): 1179-86.10.1177/030006051348850323771710
]Search in Google Scholar
[
49. Zhang L, He YL, Li QZ, Hao XH, Zhang ZF, Yuan JX, Bai YP, Jin YL, Liu N, Chen G, Yun X, Yao SQ. N-acetylcysteine alleviated silica-induced lung fibrosis in rats by down-regulation of ROS and mitochondrial apoptosis signaling. Toxicol Mech Methods 2014; 24 (3): 212-9.10.3109/15376516.2013.87997424392833
]Search in Google Scholar
[
50. Xiao Y, Xia H, Zhu L, Li X, Chen R, Yin X, Jiang Z, Feng L, Chen J, Yu M, Lou J, Zhang X. Study on the therapeutic effects of tetrandrine combined with N-acetylcysteine on experimental silicosis of rats (article in Chinese). Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2015; 33 (7): 519-22.
]Search in Google Scholar
[
51. Sun J, Song P, Wang Y, Chen Y. Clinical efficacy of acetylcysteine combined with tetrandrine tablets in the treatment of silicosis and the effect on serum IL-6 and TNF-alpha. Exp Ther Med 2019; 18 (5): 3383-8.10.3892/etm.2019.7966677725731602212
]Search in Google Scholar
[
52. Guo X, Qi J, Li H, Xing Z. Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function. Exp Ther Med 2020; 20 (2): 1285-90.10.3892/etm.2020.8858738856732765668
]Search in Google Scholar
[
53. Zhang J, Wang Y, Zhang S, Li J, Fang H. Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF- β1 and MMP-7 in silicosis patients. Exp Ther Med 2020; 19 (3): 2195-201.10.3892/etm.2020.8431702722932104284
]Search in Google Scholar
[
54. Xie QM, Tang HF, Chen JQ, Bian RL. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin 2002; 23 (12): 1107-13.
]Search in Google Scholar
[
55. Bhagya N, Chandrashekar KR. Tetrandrine--A molecule of wide bioactivity. Phytochemistry 2016; 125: 5-13.10.1016/j.phytochem.2016.02.00526899361
]Search in Google Scholar
